Brain stimulation trial hopes to restore sight in glaucoma patients

NCT ID NCT07145073

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a gentle electrical current applied to the brain (called rtACS) can wake up damaged eye cells and improve vision in people with glaucoma. 188 adults with moderate to advanced glaucoma will receive either real or sham stimulation for 10 days. The main goal is to see if their visual field (side vision) gets better after treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
repetitive transcranial alternating current stimulation (rtACS) device
What this could lead to
If it works, this could offer a new, non-invasive way to improve vision and slow damage in people with glaucoma.
What could go wrong
This is an early-stage study with no phase, so results are uncertain. The treatment is short-term and may not produce lasting benefits. Risks from brain stimulation are possible but typically mild.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLAUCOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • National Taiwan University Hospital

    RECRUITING

    Taipei, Hawaii, 100, Taiwan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.